Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Phase Ib data with Xeris' XP-0863 support progression to phase III for epilepsy

July 31, 2020

Vertex Pharmaceuticals discovers sodium channel protein type 10 subunit alpha blockers

July 31, 2020

Roche and Genentech descirbe RIPK1 inhibitors

July 31, 2020

AL-001 normalizes progranulin levels in patients with GRN gene-mutation frontotemporal dementia

July 30, 2020

Astrogen identifies new serine derivatives

July 30, 2020

Mucolipin-1 is a therapeutic target in Alzheimer's disease

July 29, 2020

Phase III REFALS trial of oral levosimendan in ALS does not meet endpoints

July 29, 2020

PIK3C2B blockade protects against ischemic stroke and preserves vascular integrity

July 29, 2020

Gruenenthal presents glucocorticoid receptor modulators

July 29, 2020

New PDE9 inhibitors synthesized at Nanjing TransThera Biosciences

July 29, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...